Amy Abernethy, a director of CM Life Sciences III Inc., has now declared ownership of 0 options from the company. The strike price of the options received was $0.00, and these expire on
Some additional info was provided as follows:
This Form 4/A amends and restates the original Form 4 filed on October 4, 2022 (the "Original Form 4"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever CM Life Sciences III Inc. makes a similar move, sign up!
